New lung drug takes first step: safety check in healthy people
Knowledge-focused
Recruiting now
This early-stage study tests a new medicine called GNS-3545 in 72 healthy adults to see if it is safe and how the body processes it. The drug is being developed for idiopathic pulmonary fibrosis, a disease that causes lung scarring. Participants will receive either the drug or a …
Phase: PHASE1 • Sponsor: Genosco Inc. • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC